Tweet

Medifirst Solutions 510(k) Submission Has Been Accepted by the FDA

FREEHOLD, NJ — (Marketwired) — 06/23/16 — MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the “Company” or “Medifirst”) would like to update shareholders regarding its 510(k) submission for its Time Machine TTML-8102000 Laser Thermal Therapeutic Device. Medifirst Solutions is pleased to announce that it has completed its response to the FDA–s request for more information and The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has received and accepted the submission and it is currently under review.

Commented President Bruce J. Schoengood, “Working very closely with our FDA consulting group, we have successfully completed the submission to the FDA within the deadline. The successful completion of the electrical and safety test, as announced last week, was the final component needed to submit the Medifirst response. We anticipate a response from the FDA in the upcoming weeks and we would like to thank shareholders for their patience and support.”

In anticipation of the 510(k) approval, Medifirst is preparing for the next phase of the operation and is currently developing its national sales, marketing and social media strategy for both domestic and international sales and distribution.

Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals, as well as everyday consumers. Medifirst is developing and establishing both consumer and professional medical cliental that can serve as a pipeline that will allow for distribution of future products and services. For more details visit for more information.

Medical Lasers Manufacturer, Inc., a Nevada company, (“MLM”), a Medifirst subsidiary, will specialize in producing high quality diode-pumped solid-state lasers. The laser division, including products and treatment programs, will be operated out of MLM. The company–s focus is to help patients with specific cosmetic skin conditions, as well as relief of muscle and joint pain and muscle spasm and inflammation. Driven by the huge demand for minimally invasive skin and pain treatments, the global market for medical and therapeutic lasers have been estimated to grow as high as to $4 billion in 2015.

Forward-Looking Statements: The statements in this press release that relate to the company–s expectations with regard to the future impact on the company–s results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company–s actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.

Medifirst Solutions, Inc.
Investor Relations
(732) 786-8044